Mehran Karimi
#160,786
Most Influential Person Now
Researcher
Mehran Karimi's AcademicInfluence.com Rankings
Mehran Karimiengineering Degrees
Engineering
#6912
World Rank
#8266
Historical Rank
Electrical Engineering
#2110
World Rank
#2215
Historical Rank
Mehran Karimicomputer-science Degrees
Computer Science
#9222
World Rank
#9688
Historical Rank
Computational Linguistics
#2188
World Rank
#2210
Historical Rank
Machine Learning
#3982
World Rank
#4030
Historical Rank
Artificial Intelligence
#4317
World Rank
#4377
Historical Rank
Download Badge
Engineering Computer Science
Mehran Karimi's Degrees
- PhD Computer Science Stanford University
- Masters Electrical Engineering University of California, Berkeley
- Bachelors Electrical Engineering University of California, Berkeley
Similar Degrees You Can Earn
Why Is Mehran Karimi Influential?
(Suggest an Edit or Addition)Mehran Karimi's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. (2011) (1558)
- Long-term safety and efficacy of factor IX gene therapy in hemophilia B. (2014) (942)
- AAV5–Factor VIII Gene Transfer in Severe Hemophilia A (2017) (453)
- A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A. (2016) (374)
- Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study. (2010) (328)
- Targeting of Antithrombin in Hemophilia A or B with RNAi Therapy (2017) (257)
- ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission (2008) (240)
- Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition) (2013) (175)
- Multiyear Follow-up of AAV5-hFVIII-SQ Gene Therapy for Hemophilia A. (2020) (157)
- β-Thalassemia Distribution in the Old World: an Ancient Disease Seen from a Historical Standpoint (2017) (150)
- Splenectomy and thrombosis: the case of thalassemia intermedia (2010) (130)
- Fibrinogen estimates are influenced by methods of measurement and hemodilution with colloid plasma expanders (2010) (128)
- Fibrinogen concentrate for acquired hypofibrinogenaemic states (2008) (127)
- Growth and endocrine disorders in thalassemia: The international network on endocrine complications in thalassemia (I-CET) position statement and guidelines (2013) (123)
- Spectrum of the Mutations in Bernard–Soulier Syndrome (2014) (120)
- Response to hydroxyurea treatment in Iranian transfusion-dependent beta-thalassemia patients. (2004) (117)
- Factor VIII brand and the incidence of factor VIII inhibitors in previously untreated UK children with severe hemophilia A, 2000-2011. (2014) (111)
- Factor XIII Deficiency. (2009) (109)
- Age‐related complications in treatment‐naïve patients with thalassaemia intermedia (2010) (108)
- Diagnosis and management of acquired coagulation inhibitors: a guideline from UKHCDO (2013) (105)
- Hematologic and Clinical Responses of Thalassemia Intermedia Patients to Hydroxyurea During 6 Years of Therapy in Iran (2005) (97)
- The use of enhanced half‐life coagulation factor concentrates in routine clinical practice: guidance from UKHCDO (2016) (95)
- Incidence of factor VIII inhibitors throughout life in severe hemophilia A in the United Kingdom. (2011) (87)
- Premarital screening for β-thalassaemia in Southern Iran: options for improving the programme (2007) (85)
- RBC alloimmunization in blood transfusion‐dependent β‐thalassemia patients in southern Iran (2007) (82)
- Adverse Effects of Prolonged Sitting Behavior on the General Health of Office Workers (2017) (78)
- Cerebral infarction in β-thalassemia intermedia: breaking the silence. (2012) (73)
- Long‐term safety and efficacy of recombinant factor VIII Fc fusion protein (rFVIIIFc) in subjects with haemophilia A (2016) (72)
- Bone mineral density in beta-thalassemia major and intermedia. (2007) (71)
- β-THALASSEMIA INTERMEDIA FROM SOUTHERN IRAN: IVS-II-1 (G→A) IS THE PREVALENT THALASSEMIA INTERMEDIA ALLELE (2002) (69)
- Multiyear Follow-up of AAV5-hFVIII-SQ Gene Therapy for Hemophilia A. (2020) (63)
- Use of recombinant factor VIIa for post‐operative haemorrhage in a patient with Glanzmann's thrombasthenia and human leucocyte antigen antibodies (2001) (62)
- Double-faced cell-mediated immunity in β-thalassemia major: stimulated phenotype versus suppressed activity (2008) (62)
- Inherited coagulation disorders in southern Iran (2002) (61)
- Guidelines for Diagnosis and Management of Beta-Thalassemia Intermedia (2014) (60)
- Assessment of the prevalence of iron deficiency anemia, by serum ferritin, in pregnant women of Southern Iran. (2002) (59)
- Patients with localized and disseminated tumors have reduced but measurable levels of ADAMTS-13 (von Willebrand factor cleaving protease). (2003) (58)
- Second international collaborative study evaluating performance characteristics of methods measuring the von Willebrand factor cleaving protease (ADAMTS‐13) (2008) (58)
- Phenotype‐genotype characterization of 10 families with severe a subunit factor XIII deficiency (2004) (54)
- Quality of life among Iranian patients with beta-thalassemia major using the SF-36 questionnaire. (2013) (53)
- Recombinant factor IX Fc fusion protein in children with haemophilia B (Kids B-LONG): results from a multicentre, non-randomised phase 3 study. (2017) (52)
- Genotype–phenotype relationship of patients with β-thalassemia taking hydroxyurea: a 13-year experience in Iran (2011) (52)
- Phenotype and genotype report on homozygous and heterozygous patients with congenital factor X deficiency (2008) (51)
- Serum ferritin level and morbidity risk in transfusion-independent patients with β-thalassemia intermedia: the ORIENT study (2014) (50)
- Replacement therapy for bleeding episodes in factor VII deficiency (2012) (50)
- Magnetic resonance imaging to determine the incidence of brain ischaemia in patients with β-thalassaemia intermedia (2010) (48)
- β‐Globin gene cluster haplotypes in sickle cell patients from southwest Iran (2003) (47)
- Prevalence of iron deficiency anemia in 6 months to 5 years old children in Fars, Southern Iran. (2003) (47)
- Combined therapy of silymarin and desferrioxamine in patients with β‐thalassemia major: a randomized double‐blind clinical trial (2009) (46)
- Echocardiographic finding in beta‐thalassemia intermedia and major: absence of pulmonary hypertension following hydroxyurea treatment in beta‐thalassemia intermedia (2009) (45)
- Cerebrovascular accident in β‐thalassemia major (β‐TM) and β‐thalassemia intermedia (β‐TI) (2008) (44)
- The prevalence of signs and symptoms of childhood leukemia and lymphoma in Fars Province, Southern Iran. (2008) (43)
- Factor XIII deficiency diagnosis: Challenges and tools (2018) (43)
- Long-acting recombinant factor VIII Fc fusion protein (rFVIIIFc) for perioperative haemostatic management in severe haemophilia A (2016) (42)
- Osteoporosis in thalassemia major: an update and the I-CET 2013 recommendations for surveillance and treatment. (2013) (41)
- Serum lipid profiles in patients with beta-thalassemia major and intermedia in southern Iran (2010) (40)
- The incidence of factor VIII inhibitors in severe haemophilia A following a major switch from full‐length to B‐domain‐deleted factor VIII: a prospective cohort comparison (2015) (40)
- Persistence of haemostatic response following gene therapy with valoctocogene roxaparvovec in severe haemophilia A (2021) (40)
- Apolipoprotein E polymorphism in Southern Iran: E4 allele in the lowest reported amounts (2008) (39)
- Consensus recommendations for the use of FEIBA® in haemophilia A patients with inhibitors undergoing elective orthopaedic and non‐orthopaedic surgery (2013) (39)
- Risk factors for pulmonary hypertension in patients with thalassemia intermedia (2010) (39)
- Serum Ferritin Levels Correlation With Heart and Liver MRI and LIC in Patients With Transfusion-Dependent Thalassemia (2015) (39)
- Developmental status of 5-year-old moderate low birth weight children (2011) (38)
- Experience of four UK comprehensive care centres using FEIBA® for surgeries in patients with inhibitors (2011) (38)
- Risk factors for pulmonary hypertension in patients with β thalassemia intermedia. (2011) (38)
- Contemporary approaches to treatment of beta-thalassemia intermedia. (2012) (38)
- Nonacog beta pegol in previously treated children with hemophilia B: results from an international open‐label phase 3 trial (2016) (38)
- Intrathoracic masses due to extramedullary hematopoiesis. (2004) (37)
- Seasonal variations in the onset of childhood leukemia/lymphoma: April 1996 to March 2000, Shiraz, Iran (2003) (37)
- ADVERSE EFFECTS OF HYDROXYUREA IN β-THALASSEMIA INTERMEDIA PATIENTS: 10 Years’ Experience (2010) (37)
- Molecular characterization of glucose-6-phosphate dehydrogenase deficiency in the Fars province of Iran. (2003) (37)
- Preliminary Data on COVID-19 in Patients with Hemoglobinopathies: A Multicentre ICET-A Study (2020) (37)
- Tailoring treatment of haemophilia B: accounting for the distribution and clearance of standard and extended half-life FIX concentrates (2017) (37)
- Eighteen unrelated patients with factor XI deficiency, four novel mutations and a 100% detection rate by denaturing high‐performance liquid chromatography (2003) (36)
- Efficiency of premarital screening of beta-thalassemia trait using MCH rather than MCV in the population of Fars Province, Iran. (2002) (36)
- Inherited Thrombophilia and Recurrent Pregnancy Loss (2013) (35)
- Source of Factor VIII Replacement (PLASMATIC OR RECOMBINANT) and Incidence of Inhibitory Alloantibodies in Previously Untreated Patients with Severe Hemophilia a: The Multicenter Randomized Sippet Study (2015) (35)
- Inhibitors in nonsevere haemophilia A: outcome and eradication strategies (2015) (34)
- Activity of Transgene-Produced B-Domain Deleted Factor VIII in Human Plasma Following AAV5 Gene Therapy. (2020) (34)
- Prevalence and mortality in β‐thalassaemias due to outbreak of novel coronavirus disease (COVID‐19): the nationwide Iranian experience (2020) (34)
- A study of the prevalence of vitamin K deficiency in patients with cancer referred to a hospital palliative care team and its association with abnormal haemostasis (2007) (34)
- Cerebral thrombosis in patients with &bgr;-thalassemia: a systematic review (2012) (33)
- The effects of economic sanctions on disease specific clinical outcomes of patients with thalassemia and hemophilia in Iran. (2015) (33)
- Novel, human cell line‐derived recombinant factor VIII (human‐cl rhFVIII; Nuwiq®) in adults with severe haemophilia A: efficacy and safety (2016) (33)
- Efficacy of prophylaxis and genotype‐phenotype correlation in patients with severe Factor X deficiency in Iran (2012) (32)
- Retrospective evaluation of bleeding tendency and simultaneous thrombin and plasmin generation in patients with rare bleeding disorders (2012) (31)
- Topiramate and Propranolol for Prophylaxis of Migraine (2013) (30)
- Immunomodulatory effects of silymarin in patients with β-thalassemia major. (2013) (30)
- Women with congenital factor VII deficiency: clinical phenotype and treatment options from two international studies (2016) (30)
- Recombinant ADAMTS13 reduces abnormally up-regulated von Willebrand factor in plasma from patients with severe COVID-19 (2021) (30)
- Prevalence of asthma among Middle Eastern children: A systematic review (2016) (29)
- Health-Related Quality of Life and Health Utility Values in Beta Thalassemia Major Patients Receiving Different Types of Iron Chelators in Iran (2016) (29)
- Multitypic Hepatitis C Virus Infection Identified by Real-Time Nucleotide Sequencing of Minority Genotypes (2006) (29)
- Adenovirus‐associated antibodies in UK cohort of hemophilia patients: A seroprevalence study of the presence of adenovirus‐associated virus vector–serotypes AAV5 and AAV8 neutralizing activity and antibodies in patients with hemophilia A (2019) (29)
- Inhibitors to factor VII in congenital factor VII deficiency (2014) (29)
- Haemophilia in the developing countries: the Iranian experience (2010) (28)
- Evaluation of the Incidence of Sensorineural Hearing Loss in Beta-Thalassemia major Patients under Regular Chelation Therapy with Desferrioxamine (2002) (28)
- Clinically significant differences between point-of-care analysers and a standard analyser for monitoring the International Normalized Ratio in oral anticoagulant therapy: a multi-instrument evaluation in a hospital outpatient setting (2007) (28)
- Fitusiran, an Investigational RNAi Therapeutic Targeting Antithrombin for the Treatment of Hemophilia: Updated Results from a Phase 1 and Phase 1/2 Extension Study in Patients without Inhibitors (2016) (27)
- Prognostic model to predict postoperative acute kidney injury in patients undergoing major gastrointestinal surgery based on a national prospective observational cohort study (2018) (26)
- First‐line immune tolerance induction for children with severe haemophilia A: A protocol from the UK Haemophilia Centre Doctors' Organisation Inhibitor and Paediatric Working Parties (2017) (26)
- Successful treatment of cyclophosphamide induced intractable hemorrhagic cystitis with recombinant FVIIa (NovoSeven®) after allogenic bone marrow transplantation (2004) (26)
- EVALUATION OF THE SERUM LEVELS OF IMMUNOGLOBULINS AND COMPLEMENT FACTORS IN B-THALASSEMIA MAJOR PATIENTS IN SOUTHERN IRAN (2005) (26)
- A rare inherited coagulation disorder: Combined homozygous factor VII and factor X deficiency (2004) (26)
- Hydroxyurea as a first-line treatment of extramedullary hematopoiesis in patients with beta thalassemia: Four case reports (2015) (26)
- Insulin-like Growth Factor-1 (IGF-1): Demographic, Clinical and Laboratory Data in 120 Consecutive Adult Patients with Thalassaemia Major (2014) (26)
- Early Echocardiographic Findings in β-Thalassemia Intermedia Patients Using Standard and Tissue Doppler Methods (2011) (25)
- Acetaminophen use and the symptoms of asthma, allergic rhinitis and eczema in children. (2006) (25)
- Hydroxyurea Treatment in Transfusion-Dependent β-Thalassemia Patients (2014) (25)
- Spectrum of inherited bleeding disorders in southern Iran, before and after the establishment of comprehensive coagulation laboratory (2009) (25)
- Malignancies in patients with β‐thalassemia major and β‐thalassemia intermedia: A multicenter study in Iran (2009) (25)
- Prevalence of beta-thalassemia trait and glucose-6-phosphate dehydrogenase deficiency in Iranian Jews. (2008) (25)
- Stabilization of fibrin clots by activated prothrombin complex concentrate and tranexamic acid in FVIII inhibitor plasma (2011) (25)
- Compliance and satisfaction with deferasirox (Exjade®) compared with deferoxamine in patients with transfusion-dependent beta-thalassemia (2014) (25)
- Prevalence of diabetes mellitus and impaired glucose tolerance in beta-thalassemia patients with and without hepatitis C virus infection. (2004) (25)
- HODGKIN LYMPHOMA DEVELOPING IN A 4.5-YEAR-OLD GIRL WITH HYPER-IgE SYNDROME (2006) (25)
- Glanzmann thrombasthenia and Bernard-Soulier syndrome in south Iran. (2005) (25)
- Pharmacokinetics, clot strength and safety of a new fibrinogen concentrate: randomized comparison with active control in congenital fibrinogen deficiency (2018) (24)
- Exposure to Second-hand Smoke During Pregnancy and Preterm Delivery (2013) (24)
- Cost-utility analysis of immune tolerance induction therapy versus on-demand treatment with recombinant factor VII for hemophilia A with high titer inhibitors in Iran (2011) (24)
- Pharmacokinetics, clot strength and safety of a new fibrinogen concentrate: randomized comparison with active control in congenital fibrinogen deficiency (2018) (24)
- Spectrum and haplotypes of the HFE hemochromatosis gene in Iran: H63D in beta-thalassemia major and the first E277K homozygous. (2004) (24)
- Intracranial hemorrhage pattern in the patients with factor XIII deficiency (2014) (24)
- An analysis of prognostic factors and the five-year survival rate in childhood acute lymphoblastic leukemia. (2002) (24)
- Effect of combination therapy of hydroxyurea with l‐carnitine and magnesium chloride on hematologic parameters and cardiac function of patients with β‐thalassemia intermedia (2010) (23)
- Molecular Basis of Hb H Disease in Southwest Iran (2005) (23)
- Comparison of Thrombin Generation Assay With Conventional Coagulation Tests in Evaluation of Bleeding Risk in Patients With Rare Bleeding Disorders (2014) (23)
- The Effect of Educational-Spiritual Intervention on The Burnout of The Parents of School Age Children with Cancer: A Randomized Controlled Clinical Trial (2016) (23)
- The first deletion mutation in the TSP1-6 repeat domain of ADAMTS13 in a family with inherited thrombotic thrombocytopenic purpura (2009) (23)
- Comparison of attitudes towards prenatal diagnosis and termination of pregnancy for haemophilia in Iran and Italy (2004) (22)
- Distribution of alpha-thalassemia mutations in Iranian population (2015) (22)
- Seroprevalence of Human Herpes Simplex, Hepatitis B and Epstein-Barr Viruses in Children with Acute Lymphoblastic Leukemia in Southern Iran (2010) (22)
- Allele Frequency of CYP2C9 Gene Polymorphisms in Iran (2002) (22)
- Gonadal dysfunction in adult male patients with thalassemia major: an update for clinicians caring for thalassemia (2017) (22)
- The Efficacy of a Neonatal Screening Programme in Decreasing the Hospitalization Rate of Patients with G6pd Deficiency in Southern Iran (2010) (21)
- Hydroxyurea in the Management of Thalassemia Intermedia (2009) (21)
- Mutational screening of six afibrinogenemic patients: Identification and characterization of four novel molecular defects (2007) (21)
- Is beta-thalassemia trait a protective factor against hypertension in young adults? (2006) (21)
- Relationship Between Serum Hepcidin and Ferritin Levels in Patients With Thalassemia Major and Intermedia in Southern Iran (2015) (21)
- Multi Centric Origin of Hb D-Punjab [β121(GH4)Glu→Gln, GAA>CAA] (2009) (21)
- Prevalence of hepatosplenomegaly in beta thalassemia minor subjects in Iran. (2009) (21)
- Efficacy and safety of a new human fibrinogen concentrate in patients with congenital fibrinogen deficiency: an interim analysis of a Phase III trial (2018) (20)
- Frequency and distribution of asymptomatic brain lesions in patients with β-thalassemia intermedia (2012) (20)
- Attitude Toward Prenatal Diagnosis for β-Thalassemia Major and Medical Abortion in Southern Iran (2010) (20)
- Further evidence of false negative screening for lupus anticoagulants. (2008) (20)
- Diagnostic accuracy study of a factor VIII ELISA for detection of factor VIII antibodies in congenital and acquired haemophilia A (2015) (20)
- Successful delivery in patients with FXIII deficiency receiving prophylaxis: report of 17 cases in Iran (2012) (20)
- Bleeding symptoms in heterozygous carriers of inherited coagulation disorders in southern Iran (2011) (20)
- The pregnancy outcome in patients with minor β-thalassemia (2011) (19)
- Implications of SARSr-CoV 2 infection in thalassemias: Do patients fall into the “high clinical risk” category? (2020) (19)
- Treatment burden, haemostatic strategies and real world inhibitor screening practice in non‐severe haemophilia A (2017) (19)
- Clinical response of patients with sickle cell anemia to cromolyn sodium nasal spray (2006) (19)
- Is β-thalassemia trait a protective factor against hypertension in young adults? (2005) (19)
- Hypoparathyroidism and intracerebral calcification in patients with beta-thalassemia major. (2009) (19)
- Factor XIII deficiency: a review of literature (2012) (19)
- Cancer-Associated Thrombosis (2010) (18)
- Fibrinogen concentrate for treatment of bleeding and surgical prophylaxis in congenital fibrinogen deficiency patients (2019) (18)
- The frequency of silent cerebral ischemia in patients with transfusion-dependent β-thalassemia major (2015) (18)
- Interindividual variability in transgene mRNA and protein production following adeno-associated virus gene therapy for hemophilia A (2022) (18)
- Combination therapy – deferasirox and deferoxamine – in thalassemia major patients in emerging countries with limited resources (2015) (18)
- Arg77His and Trp187Arg are the Most Common Mutations Causing FXIII Deficiency in Iran (2012) (18)
- Cost–utility analysis of oral deferasirox versus infusional deferoxamine in transfusion‐dependent β‐thalassemia patients (2013) (18)
- Maternal and Prenatal Risk Factors for Childhood Leukemia in Southern of Iran (2011) (18)
- Causes for Hospitalization and Death in Iranian Patients with β-Thalassemia Major (2011) (17)
- Sociocultural challenges of beta-thalassaemia major birth in carriers of beta-thalassaemia in Iran (2012) (17)
- The burden and management of FXIII deficiency (2014) (17)
- Adult haemophilia A patients with inhibitors: successful immune tolerance induction with a single FVIII/VWF product (2014) (17)
- Long‐term outcome of haemophilia A patients after successful immune tolerance induction therapy using a single plasma‐derived FVIII/VWF product: the long‐term ITI study (2016) (17)
- Survival Rate of Childhood Leukemia in Shiraz, Southern Iran (2013) (17)
- A Comparison Between Recombinant Activated Factor VII (Aryoseven) and Novoseven in Patients With Congenital Factor VII Deficiency (2015) (17)
- Comparative study of pulmonary circulation and myocardial function in patients with β‐thalassemia intermedia with and without hydroxyurea, a case–control study (2011) (17)
- Cerebrovascular accident in beta-thalassemia major (beta-TM) and beta-thalassemia intermedia (beta-TI). (2008) (17)
- Molecular characterization of 11 novel mutations in patients with heterozygous and homozygous FV deficiency (2010) (17)
- Prevalence of endocrine disorders and their associated factors in transfusion-dependent thalassemia patients: a historical cohort study in Southern Iran (2019) (16)
- A Comparison of Efficacy Between Recombinant Activated Factor VII (Aryoseven) and Novoseven in Patients With Hereditary FVIII Deficiency With Inhibitor (2016) (16)
- Termination of pregnancy due to Thalassemia major, Hemophilia, and Down's Syndrome: the views of Iranian physicians (2008) (16)
- Hepatitis C Virus Antibody Positive Cases in Multitransfused Thalassemic Patients in South of Iran (2007) (16)
- Pharmacokinetic and pharmacodynamic properties of plasma‐derived vs. recombinant factor IX in patients with hemophilia B: a prospective crossover study (2014) (15)
- Is beta-thalassemia trait a protective factor against ischemic cerebrovascular accidents? (2008) (15)
- Pharmacokinetics, coagulation factor consumption and clinical efficacy in patients being switched from full‐length FVIII treatment to B‐domain‐deleted r‐FVIII and back to full‐length FVIII (2009) (15)
- A Subcutaneously Administered Investigational RNAi Therapeutic (ALN-AT3) Targeting Antithrombin for Treatment of Hemophilia: Interim Weekly and Monthly Dosing Results in Patients with Hemophilia A or B (2015) (15)
- Survival and causes of death in 2,033 patients with non-transfusion-dependent β-thalassemia (2021) (15)
- Bleeding symptoms in patients diagnosed as type 3 von Willebrand disease: Results from 3WINTERS‐IPS, an international and collaborative cross‐sectional study (2020) (15)
- Genetic characterization of patients with Bernard-Soulier syndrome and their relatives from Southern Iran (2007) (15)
- Sickle cell disease and COVID‐19: Susceptibility and severity (2020) (15)
- Long‐term prophylaxis in patients with factor XIII deficiency complicated by intracranial haemorrhage in Iran (2010) (15)
- Analysis of intelligence quotient in patients with homozygous beta-thalassemia. (2006) (15)
- Evaluation of Thrombin Generation Assay in Patients With Hemophilia (2014) (15)
- Serum Ferritin Levels and Morbidity in β-Thalassemia Intermedia: A 10-Year Cohort Study (2012) (14)
- Global longitudinal strain as an Indicator of cardiac Iron overload in thalassemia patients (2019) (14)
- The effect of educational intervention on decreasing mothers' expressed breast milk bacterial contamination whose infants are admitted to neonatal intensive care unit. (2012) (14)
- Replacement therapy in inherited factor VII deficiency: occurrence of adverse events and relation with surgery (2015) (14)
- Comparison of Quality of Life in Patients with β-Thalassemia Intermedia and β-Thalassemia Major in Southern Iran (2017) (14)
- A comparison of heart function and arrhythmia in clinically asymptomatic patients with beta thalassemia intermedia and beta thalassemia major (2017) (13)
- Correlation of serum ferritin levels with hepatic MRI T2 and liver iron concentration in nontransfusion beta-thalassemia intermediate patients: A contemporary issue (2017) (13)
- A Concise Review on the Frequency, Major Risk Factors and Surveillance of Hepatocellular Carcinoma (HCC) in β-Thalassemias: Past, Present and Future Perspectives and the ICET-A Experience (2020) (13)
- Reduced insulin growth factor I concentrations in iron-overloaded beta thalassaemic patients with normal growth hormone secretion and liver function. (2004) (13)
- Use of Glubran 2 and Glubran tissue skin adhesive in patients with hereditary bleeding disorders undergoing circumcision and dental extraction (2011) (13)
- Factors Impacting Quality of Life in Thalassemia Patients; Results from the Intercontinenthal Collaborative Study (2016) (13)
- Pregnancy outcomes in asthmatic women. (2008) (13)
- An ICET- A survey on hypoparathyroidism in patients with thalassaemia major and intermedia: a preliminary report (2018) (13)
- Purple toe syndrome following anticoagulant therapy (2001) (13)
- Pulmonary Function Test in Transfusion-Dependent β-Thalassemia Major Patients: A Pilot Study (2011) (13)
- Non-Hodgkin Lymphoma in a Child with Schimke Immuno-Osseous Dysplasia (2011) (13)
- Major Causes of Hospital Admission in Beta Thalassemia Major Patients in Southern Iran (2011) (13)
- Initial Presentation of Acute Lymphoblastic Leukemia with Osteoporosis and Multiple Spontaneous Bone Fractures (2011) (13)
- Erythrocyte folate and 5-methyltetrahydrofolate levels decline during 6 months of oral anticoagulation with warfarin (2009) (13)
- Is β-thalassemia trait a risk factor for developing depression in young adults? (2006) (12)
- Radiofrequency ablation of the spleen in patients with thalassemia intermedia: a pilot study. (2009) (12)
- American Society of Cytopathology (2002) (12)
- Fitusiran, an Investigational siRNA Therapeutic Targeting Antithrombin for the Treatment of Hemophilia: First Results from a Phase 3 Study to Evaluate Efficacy and Safety in People with Hemophilia a or B without Inhibitors (ATLAS-A/B) (2021) (12)
- The Frequency of Adrenal Insufficiency in Adolescents and Young Adults with Thalassemia Major versus Thalassemia Intermedia in Iran (2014) (12)
- Acquired agranulocytosis and factor XI deficiency in association with thymoma. (2011) (12)
- Compliance of deferoxamine injection in beta‐thalassaemia major patients in Iran (2012) (12)
- Intracranial Blood Flow Velocity in Patients with β-Thalassemia Intermedia Using Transcranial Doppler Sonography: A Case-Control Study (2011) (12)
- Bone mineral density in Iranian patients with haemophilia: the first experience in southern Iran (2011) (12)
- Subclassification of Localized Leishmania Lymphadenitis in Fine Needle Aspiration Smears (2001) (12)
- Association between Helicobacter pylori Infection and Iron Deficiency Anemia in School-aged Iranian Children (2019) (12)
- Investigation of Helicobacter pylori infection in &bgr;-thalassaemia major patients with recurrent abdominal pain (2005) (12)
- Genotype and phenotype report on patients with combined deficiency of factor V and factor VIII in Iran (2014) (12)
- Clinical and laboratory patterns of the haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura in southern Iran (2006) (11)
- Vaccine-Induced Anti-HBs Level in 5-6 Year-Old Malnourished Children (2013) (11)
- Nicolau syndrome following intramuscular penicillin injection. (2012) (11)
- The Effect of Yoga on the Quality of Life in the Children and Adolescents with Haemophilia (2015) (11)
- Ultrasonographic assessment of the prevalence of cholelithiasis and biliary sludge in beta-thalassemia patients in Iran. (2009) (11)
- Fine Needle Aspiration of Langerhans Cell Histiocytosis of the Lymph Nodes (2002) (11)
- Efficacy of Deferasirox (Exjade®) in Modulation of Iron Overload in Patients with β-Thalassemia Intermedia (2015) (11)
- Highlights from the First Thalassaemia Forum on Growth and Endocrine Complications in Thalassemia Doha, (October 2-3, 2011). (2012) (11)
- Diagnosis and management of acquired coagulation inhibitors : a guideline from UKHCDO A United Kingdom Haemophilia Centre Doctors ’ Organization ( UKHCDO ) guideline approved by the British Committee for Standards in Haematology (2013) (11)
- Effectiveness of β‐thalassemia prenatal diagnosis in Southern Iran: a cohort study (2015) (10)
- Substance dependency in Iranian patients with hemophilia. (2007) (10)
- Molecular Analysis Of The Largest Group Of Patients With Factor XIII Deficiency In Southeast Of Iran (2013) (10)
- Prevalence and Severity of Coronavirus Disease 2019 (COVID-19) in Transfusion Dependent and Non-Transfusion Dependent β -Thalassemia Patients and effects of Associated Comorbidities: An Iranian Nationwide study (2020) (10)
- Initial presentation of childhood leukaemia with facial palsy: three case reports (2009) (10)
- Genotype-phenotype correlation related to lipid profile in beta-thalassemia major and intermedia in southern Iran. (2012) (10)
- Malignant epithelioid hemangioendothelioma of the bladder: the first case report in a child. (2009) (10)
- Frequency of Thalassemia, Iron and Glucose-6Phosphate Dehydrogenase Deficiency Among Turkish Migrating Nomad Children in Southern Iran (2009) (10)
- THALASSEMIA, IRON AND G6PD DEFICIENCY IN LOR MIGRATING NOMAD CHILDREN, SOUTHERN IRAN (2010) (10)
- Erratum: “Cerebrovascular accident in β‐thalassemia major (β‐TM) and β‐thalassemia intermedia (β‐TI)” by Karimi et al. Am J Hematol 83:77–79, 2008, DOI number 20938 (2010) (10)
- Attitudes of haemophilic patients towards their health and socio‐economic problems in Iran (2012) (10)
- Risk of mortality from anemia and iron overload in nontransfusion‐dependent β‐thalassemia (2021) (9)
- Antithrombotic prophylaxis in children and adolescent patients with SARS-CoV-2 (COVID-19) infection: A practical guidance for clinicians (2020) (9)
- Determining and Surveying the Role of Carnitine and Folic Acid to Decrease Fatigue in β-Thalassemia Minor Subjects (2013) (9)
- Low frequency of elevated prothrombin times in patients with lupus anticoagulants when using a recombinant thromboplastin reagent: implications for dosing and monitoring of oral anticoagulant therapy (2005) (9)
- Is beta-thalassemia trait a risk factor for developing depression in young adults? (2006) (9)
- Antibiotic Use and Symptoms of Asthma, Allergic Rhinitis and Eczema in Children (2009) (9)
- Epidemiological surveillance of pediatric Hodgkin's disease in southern Iran. (2002) (9)
- Evaluation of the FXIII deficiency prophylaxis intervals in large number of FXIII deficiency patients from Iran (2013) (9)
- Successful delivery in an patient with afibrinogenemia after three abortions: A case report and review of the literature (2018) (9)
- Delay in Diagnosis of Hemoglobulinopathies (Thalassemia, Sickle Cell Anemia): A Need for Management of Thalassemia Programs (2016) (9)
- Efficacy of Carvedilol in Patients with Dilated Cardiomyopathy due to Beta-thalassemia major; a Double-blind Randomized Controlled Trial (2010) (9)
- Coronavirus Disease 2019 (COVID-19) Severity in Patients with Thalassemias: A Nationwide Iranian Experience (2021) (9)
- Efficacy and safety of resveratrol, an oral hemoglobin F-augmenting agent, in patients with beta-thalassemia intermedia (2018) (9)
- Synoviorthesis induced by rifampicin in hemophilic arthropathy: a report of 24 treated joints (2011) (9)
- Zidovudine-induced pure red cell aplasia presenting after 4 years of therapy. (2005) (9)
- Apolipoprotein E gene polymorphism and left ventricular function in Iranian patients with thalassemia major. (2007) (9)
- Spontaneous perforation of the common bile duct with eosinophilia in an 18-month-old girl: a case report and review of literature. (2006) (9)
- Second interim analysis results from the STASEY trial: A single-arm, multicentre, open-label, phase III clinical trial to evaluate the safety and tolerability of emicizumab prophylaxis in persons with haemophilia A (PwHA) with FVIII inhibitors (2021) (9)
- Pet exposure and the symptoms of asthma, allergic rhinitis and eczema in 6-7 years old children. (2011) (9)
- Severe hemophilia in a girl infant with mosaic Turner syndrome and persistent hyperplastic primary vitreous (2016) (9)
- Efficacy of fibrinogen concentrate in major abdominal surgery – A prospective, randomized, controlled study in cytoreductive surgery for pseudomyxoma peritonei (2019) (9)
- Cytology of Leukemic Lymphadenopathy (2002) (8)
- Breastfeeding as a Protective Effect Against Childhood Leukemia and Lymphoma (2016) (8)
- Thrombosis in pediatric malignancy: a review and future perspectives with focus on management (2018) (8)
- A Comprehensive Update of ICET-A Network on COVID-19 in Thalassemias: What We Know and Where We Stand (2020) (8)
- Incidence Rate of COVID-19 Infection in Hemoglobinopathies: A Systematic Review and Meta-analysis (2021) (8)
- The Activated Seven Lupus Anticoagulant Assay Detects Clinically Significant Antibodies (2008) (8)
- Factor XI deficiency in Southern Iran: identification of a novel missense mutation (2009) (8)
- Prophylactic effect of recombinant factor VIIa with congenital factor VII deficiency (2008) (8)
- Efficacy and Safety of Fitusiran Prophylaxis, an siRNA Therapeutic, in a Multicenter Phase 3 Study (ATLAS-INH) in People with Hemophilia A or B, with Inhibitors (PwHI) (2021) (8)
- The ICET-A Survey on Current Criteria Used by Clinicians for the Assessment of Central Adrenal Insufficiency in Thalassemia: Analysis of Results and Recommendations (2016) (8)
- Successful control of central nervous system bleeding in two newborns with severe factor VII deficiency using rFVIIa administered via Port-a-Cath. (2008) (8)
- Diffuse intracerebral calcification in a beta-thalassaemia major patient with hypoparathyroidism: a case report. (2011) (8)
- Effect of Coping Strategies Training On Its Use by Thalassemia Major Adolescents: A Randomized Controlled Clinical Trial (2015) (8)
- Hypothyroidism in β-Thalassemia Intermedia Patients with and without Hydroxyurea (2014) (8)
- Evaluation of Efficacy, Safety, and Satisfaction Taking Deferasirox Twice Daily Versus Once Daily in Patients With Transfusion-Dependent Thalassemia (2019) (7)
- Long‐term follow‐up of prophylaxis with recombinant activated factor VII in patients with congenital factor VII deficiency (2011) (7)
- Short stature in beta-thalassemia minor subjects. (2004) (7)
- Survival Analysis of Transfusion Dependent β-Thalassemia Major Patients (2006) (7)
- Three dominant‐negative mutations in factor XI‐deficient patients (2011) (7)
- The Quality of Life of Children with Hemophilia in Shiraz, Iran (2013) (7)
- Predictive Role of Haematological Determinants on Outcomes of Critically Ill COVID-19 Patients Admitted to Intensive Care Unit (2021) (7)
- Iranian experience of deferasirox (Exjade®) in transfusion-dependent patients with iron overload: what is the most effective dose based on serum ferritin levels? (2012) (7)
- First-in-Human Phase 1/2 Clinical Trial of SIG-001, an Innovative Shielded Cell Therapy Platform, for Hemophilia Α (2020) (7)
- Comparative study of hypogonadism in beta-thalassemia intermedia patients with and without hydroxyurea (2012) (7)
- Diagnosis and management of von Willebrand disease in Iran. (2011) (7)
- Hyperhomocysteinemia and B-Vitamin Status after Discontinuation of Oral Anticoagulation Therapy in Patients with a History of Venous Thromboembolism (2003) (6)
- Unexpected postmortem diagnosis of acanthamoeba meningoencephalitis in an immunocompetent child (2011) (6)
- Efficacy and safety of Nuwiq® (human‐cl rhFVIII) in patients with severe haemophilia A undergoing surgical procedures (2018) (6)
- Clinical overview of Fanhdi/Alphanate (plasma‐derived, VWF‐containing FVIII concentrate) in immune tolerance induction in haemophilia A patients with inhibitors (2016) (6)
- Quality of Life in Children and Adolescents With Rare Bleeding Disorders in Southern Iran (2017) (6)
- Modified Primary Prophylaxis in Previously Untreated Patients With Severe Hemophilia A in Iran (2018) (6)
- Ocular complication and visual evoked potential in β-thalassemia patients on desferal therapy. (2009) (6)
- Prevalence of glucose dysregulation (GD) in patients with β-thalassemias in different countries: A preliminary ICET-A survey (2021) (6)
- Adeno-Associated Viral Vector Mediated Gene Transfer for Hemophilia B (2011) (6)
- Frequency of silent brain lesions and aspirin protection evaluation over 3 years follow-up in beta thalassemia patients (2019) (6)
- A complication risk score to evaluate clinical severity of thalassaemia syndromes (2020) (6)
- Clinical characteristics, biochemical parameters and insulin response to oral glucose tolerance test (OGTT) in 25 transfusion dependent β-thalassemia (TDT) patients recently diagnosed with diabetes mellitus (DM) (2022) (6)
- Inhibitors of coagulation (2011) (6)
- Evaluation of endocrine complications in beta-thalassemia intermedia (β-TI): a cross-sectional multicenter study (2019) (6)
- Does Helicobacter pylori play a role in the pathogenesis of childhood chronic idiopathic thrombocytopenic purpura? (2009) (6)
- Marital status and paternity in patients with Transfusion-Dependent Thalassemia (TDT) and Non Transfusion-Dependent Thalassemia (NTDT): an ICET - A survey in different countries (2019) (6)
- Frequency of Cholelithiasis in Patients With Beta-Thalassemia Intermedia With and Without Hydroxyurea (2014) (6)
- Inhibitors against rFVIIa in patients with severe congenital FVII deficiency: A case series (2019) (6)
- Frequency of Celiac Disease in Children with Beta Thalassemia major (2014) (5)
- Health status in Iranian haemophilic patients (2008) (5)
- Malignant sarcoma masquerading as a pseudotumour in a patient with mild haemophilia (2003) (5)
- The protective effects of Ginkgo biloba extract in decreasing hemolysis of RBC in Glucose-6-phosphate dehydrogenase-deficient patients. (2007) (5)
- Rapid and sustained immune tolerance to inhibitors induced by a plasma‐derived, VWF‐containing FVIII concentrate (2019) (5)
- Quality of Life in Hemophilia Complicated by Inhibitors (2012) (5)
- Hypo-pigmented mycosis fungoides is a rare malignancy in pediatrics. (2018) (5)
- Achievement of Normal Circulating Factor VIII Activity Following Bmn 270 AAV5-FVIII Gene Transfer: Interim, Long-Term Efficacy and Safety Results from a Phase 1/2 Study in Patients with Severe Hemophilia a (2017) (5)
- Infantile fibrosarcoma of ethmoid sinus, misdiagnosed as an adenoid in a 5-year-old child (2015) (5)
- RELATIONSHIP BETWEEN STRESS DURING PREGNANCY AND CORD BLOOD IGE LEVEL (2012) (5)
- Evaluation of Plasma Platelet Microparticles in Thrombotic Thrombocytopenic Purpura. (2017) (5)
- Long-Term Safety and Efficacy of rFVIIIFc in Adults and Adolescents with Severe Hemophilia A: A Longitudinal Analysis of A-LONG and ASPIRE (2015) (5)
- Pharmacokinetics Of Recombinant Factor IX Fc Fusion Protein (rFIXFc) In Pediatric Subjects With Hemophilia B: An Interim Analysis Of The Kids B-LONG Study (2013) (5)
- Efficacy and Safety of Sinopharm Vaccine for SARS-CoV-2 and breakthrough infections in Iranian Patients with Hemoglobinopathies: A Preliminary Report (2022) (5)
- Long-Term Safety and Efficacy of Recombinant Factor VIII FC (RFVIIIFC) in Adults and Adolescents With Severe Haemophilia A: An Interim Analysis of The ASPIRE Study (2015) (5)
- An MTHFR variant, plasma homocysteine levels and late-onset coronary artery disease in subjects from southern Iran. (2013) (5)
- Erratum: Glazmann thrombasthenia and Bernard Soulier syndrome in South Iran (Clinical and Laboratory Haematology (2005) 27, (324-327)) (2006) (5)
- Comparative Study of Radiographic and Laboratory Findings Between Beta Thalassemia Major and Beta Thalassemia Intermedia Patients With and Without Treatment by Hydroxyurea (2015) (5)
- Detection of Hb Setif in North Iran and the Question of Its Origin: Iranian or Multiethnic? (2011) (5)
- Safety, Efficacy and Pharmacokinetics of Nonacog Beta Pegol (N9-GP) in Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Pediatric Hemophilia B Patients (2014) (5)
- Bacterial Contamination of Expressed Breast Milk in Neonatal Intensive Care Unit (2013) (5)
- A lump on the head (2008) (5)
- The pregnancy outcome in patients with minor β (2012) (5)
- How to deal with medical and social aspects of bleeding disorders – preparing women and the family in developing countries (2011) (5)
- Frequency of Sensory Neural Hearing Loss in Major Beta-Thalassemias in Southern Iran (2010) (5)
- Thyroid function and stress hormones in children with stress hyperglycemia (2012) (5)
- A comparison between MRI, sonography and Functional Independence Score in Haemophilia methods in diagnosis, evaluation and classification of arthropathy in severe haemophilia A and B (2016) (5)
- Sociocultural challenges of thalassemia birth in Islamic and developing countries. (2008) (5)
- Relationship Between Some Single-nucleotide Polymorphism and Response to Hydroxyurea Therapy in Iranian Patients With &bgr;-Thalassemia Intermedia (2017) (5)
- Residual pyruvate kinase activity in PKLR‐deficient erythroid precursors of a patient suffering from severe haemolytic anaemia (2017) (5)
- A Case Report of Congenital Insensitivity to Pain and Anhidrosis (CIPA) (2012) (5)
- Changing epidemiology of the hemolytic uremic syndrome and thrombotic thrombocytopenic purpura in southern Iran (2006) (5)
- Alteration in the laboratory profile of a lupus anticoagulant in a patient with non-Hodgkin's lymphoma. (2004) (4)
- EDUCATIONAL NEEDS OF FAMILY PHYSICIANS IN YAZD PROVINCE (2012) (4)
- The frequency of hypothyroidism and its relationship with HCV positivity in patients with thalassemia major in southern Iran (2018) (4)
- Epidemiology of Hereditary Coagulation Bleeding Disorders: A 15-Year Experience From Southern Iran (2017) (4)
- Trends in 5-, 10-, 20-, and 30-year survival rates of beta-thalassemia patients in Southern Iran, 1995-2016: A retrospective cohort study (2017) (4)
- An experience of using Traumastem P in control of spontaneous nose bleeding in patients with inherited bleeding disorders in southern Iran (2014) (4)
- Phenotype Report on Patients with Congenital Factor V Deficiency in Southern Iran: Recent Ten Years’ Experience (2017) (4)
- A Large-Scale Prospective Cohort Study on Factor XIII Deficiency in Southeast of Iran (2016) (4)
- GENE THERAPY ACCESS: GLOBAL CHALLENGES, OPPORTUNITIES AND VIEWS FROM BRAZIL, SOUTH AFRICA, AND INDIA. (2022) (4)
- Prophylactic Program in fxiii Deficient Patients From Iran (2012) (4)
- A Subcutaneously Administered Investigational RNAi Therapeutic, Fitusiran (ALN-AT3), Targeting Antithrombin for Treatment of Hemophilia: Interim Results in Patients with Hemophilia A or B (2016) (4)
- A large case series on surgical outcomes in congenital factor XIII deficiency patients in Iran (2017) (4)
- Evaluation of Knowledge of Patients with Hemophilia Regarding Their Diseases and Treatment in Iran (2016) (4)
- Prevalence and clinical features of COVID-19 in Iranian patients with congenital coagulation disorders. (2020) (4)
- Evaluation of Red Cell Membrane Cytoskeletal Disorders Using a Flow Cytometric Method in South Iran (2014) (4)
- Evaluation of Heart Function in Patients With Hemophilia (2017) (4)
- The Effects of Computer-based Educational Games on Self-efficacy of 8-12 Children with Hemophilia (2015) (4)
- The PAI-I Gene 4G/5G Polymorphism and Central Nervous System Bleeding In Factor XIII Deficiency (2013) (4)
- Primary HBB gene mutation severity and long‐term outcomes in a global cohort of β‐thalassaemia (2021) (4)
- Epidemiology of Hemoglobinopathies and Thalassemias in Individuals Referred to the Haematology Research Centre, Shiraz University of Medical Sciences, Shiraz, Iran From 2006 to 2011 (2014) (4)
- Cytology of brain metastasis of yolk sac tumor. (2005) (4)
- Family Planning Practices in Families with Children Affected by β-Thalassemia Major in Southern Iran (2013) (4)
- Screening for glucose dysregulation in β-thalassemia major (β-TM): An update of current evidences and personal experience (2022) (4)
- Socially accountable medical education (2013) (4)
- Frequency of silent cerebral ischemia in patients with transfusion-dependent β-thalassemia major compared to healthy individuals (2016) (4)
- The impact of inhibitors on the cost of clotting factor replacement therapy in hemophilia A in south of Iran. (2009) (4)
- Intrathecal Autologous Bone Marrow-Derived Hematopoietic Stem Cell Therapy in Neurological Diseases (2018) (4)
- Insulin-like growth factor-1 levels in children with Beta-thalassemia minor. (2008) (4)
- Beta Thalassemia Minor as a Risk Factor for Suicide and Violence: A Failure to Replicate (2010) (4)
- T-cell lymphoblastic lymphoma of the sternum. (2010) (4)
- Experience on Using Prothrombin Complex Concentrate in Urgent Warfarin Reversal (2013) (4)
- Longitudinal Assessment of Thrombin Generation in Patients with Hemophilia Receiving Fitusiran Prophylaxis: Phase II Study Results (2020) (3)
- Vitamin D level, lipid profile, and vitamin D receptor and transporter gene variants in sickle cell disease patients from Kurdistan of Iraq (2021) (3)
- The effect of metoprolol succinate on the cardiac function of patients with thalassaemia cardiomyopathy: a double-blind randomised study (2014) (3)
- The Prevalence of Hypothyroidism among Patients With β-Thalassemia: A Systematic Review and Meta-Analysis of Cross-Sectional Studies (2021) (3)
- Management of Bleeding in Post-liver Disease, Surgery and Biopsy in Patients With High Uncorrected International Normalized Ratio With Prothrombin Complex Concentrate: An Iranian Experience (2013) (3)
- The Diagnostic Approach to Central Adrenocortical Insufficiency (CAI) in Thalassemia (2016) (3)
- A FIRST-IN-HUMAN FOUR-YEAR FOLLOW-UP STUDY OF DURABLE THERAPEUTIC EFFICACY AND SAFETY OF AAV GENE THERAPY WITH VALOCTOCOGENE ROXAPARVOVEC FOR SEVERE HEMOPHILIA A (2020) (3)
- Evaluation of cardiac sequelae in patients with sickle cell anemia. (2015) (3)
- Evaluation of the Relationship Between Hb F Levels and Nucleated Red Blood Cells with Morbidity in Non Transfusion-Dependent Thalassemia Patients (2016) (3)
- Incidence of testicular microlithiasis in patients with β-thalassemia major (2015) (3)
- The clinical implications of ADAMTS13 function: the perspectives of haemostaseologists. (2013) (3)
- TYPE OF FUEL CONSUMED AND FREQUENCY OF LORRY PASSING ASSOCIATED WITH ALLERGIC RHINITIS AND ASTHMA SYMPTOMS IN CHILDREN (2005) (3)
- Prevalence of Delta Beta Thalassemia Minor in Southern Iran (2012) (3)
- The effect of curcumin on serum copper, zinc, and zinc/copper ratio in patients with β-thalassemia intermedia: a randomized double-blind clinical trial (2021) (3)
- Pharmacokinetic (PK) Comparison of Two Fibrinogen Concentrates for the Treatment of Congenital Fibrinogen Deficiency (2014) (3)
- Pharmacokinetic (PK) Comparison of Two Fibrinogen Concentrates in Patients with Congenital Fibrinogen Deficiency: Final Analysis (2015) (3)
- Cerebral Artery Velocity Determined by Transcranial Doppler Ultrasonography in Patients With β-Thalassemia Intermedia Compared to β-Thalassemia Major (2013) (3)
- A Number of Cases in Iran Presenting with Coinheritance of Hemoglobin-H Disease and Beta-Thalassemia Minor (2016) (3)
- Genotypes of European and Iranian patients with type 3 von Willebrand disease enrolled in 3WINTERS-IPS. (2021) (3)
- Prevalence and intensity of depression in mothers of children with beta-thalassemia major in Talghani Hospital of Gorgan, Iran (2014) (3)
- Is the apolipoprotein E4 allele always hazardous? Serum uric acid level as a conflict. (2012) (3)
- Are Bleeding Scores Predicting Severity and Outcome in Hemophilia and Rare Bleeding Disorders (2016) (3)
- Attitudes and practices with regard to circumcision in haemophilia patients in Southern Iran (2013) (3)
- A retrospective study on clinical manifestations of neonates with FXIII-A deficiency. (2019) (3)
- Incidental finding of Hodgkin’s disease following initial presentation with traumatic haematoma in the thoracic inlet (2008) (3)
- Trace Elements in Children with Acute Lymphoblastic Leukemia (2020) (3)
- The impact of educating parents of leukaemic children on the healthy siblings' quality of life. (2013) (3)
- Long Term Follow up Study on a Large Group of Patients with Congenital Factor XIII Deficiency Treated Prophylactically with Fibrogammin P® (2016) (3)
- Pharmacokinetic (PK) Comparison of Two Fibrinogen Concentrates for the Treatment of Congenital Fibrinogen Deficiency (2014) (3)
- Home therapy and the effect of educational programmes in Iran; an alternative treatment option in developing countries (2009) (3)
- Prevalence of thalassaemia, iron-deficiency anaemia and glucose-6-phosphate dehydrogenase deficiency among Arab migrating nomad children, southern Islamic Republic of Iran. (2014) (3)
- Fitusiran prophylaxis in people with severe haemophilia A or haemophilia B without inhibitors (ATLAS-A/B): a multicentre, open-label, randomised, phase 3 trial. (2023) (3)
- The correlation between gene mutations and inhibitor development in patients with haemophilia A in southern Iran (2011) (3)
- P4 Survey of coagulation disorders in women with idiopathic menorrhagia (2009) (3)
- Pharmacokinetic (PK) Comparison of Two Fibrinogen Concentrates in Patients with Congenital Fibrinogen Deficiency: Final Analysis (2015) (3)
- Cost of care in Iranian hemophilic patients (2007) (3)
- Generalized tonic-clonic seizures in a thalassemic patient with hypoparathyroidism and brain calcinosis. (2011) (3)
- Blood transfusion versus hydroxyurea in beta-thalassemia in Iran: a cost-effectiveness study (2018) (3)
- Evaluation of Proteinuria in &bgr;-Thalassemia Major Patients With and Without Diabetes Mellitus Taking Deferasirox (2017) (3)
- Clinical Manifestations and Bleeding Episodes Among Heterozygote Individuals of Factor XIII Deficiency, a Short Term Prospective Study (2014) (3)
- Evaluation of the Effect of Support-Training System of Peer Group on Promotion of Self-Care in β-Thalassemia Major Patients in Southern Iran (2019) (3)
- Management of Refractory/Relapsed Acute Leukemia with Heart Limitation by Anthracycline-free Chemotherapy Regimens in Pediatric Patients: New Hypothesis and New Approach (2018) (2)
- The prevalence of oral manifestations in children with hematologic malignancys (2012) (2)
- Evaluation of bone mineral density in patients with hemoglobin H disease (2016) (2)
- Unusual Presentation of T-cell non-Hodgkin Lymphoma with Multiple Skin Nodules (2012) (2)
- Correlation of bleeding score with frequency and severity of bleeding symptoms in FXIII deficiency assessing by the ISTH Bleeding Assessment Tool. (2019) (2)
- Combined α-thalassemia and Hemoglobin J-Iran (β77 His → Asp). A Family Study in southern Iran (2011) (2)
- LIVER ENZYME ASSESSMENT IN THALASSEMIA MAJOR PATIENTS WHO UNDERWENT BONE MARROW TRANSPLANTATION, SHIRAZ 2002 (2004) (2)
- Transcranial Doppler Screening in 50 Patients With Sickle Cell Hemoglobinopathies in Iran. (2017) (2)
- Frequency of afterload homocysteinemia in normal population of Southern Iran: a pilot study. (2010) (2)
- Leptin and ghrelin serum concentrations in thalassemia major and intermedia patients and normal subjects (2010) (2)
- Congenital Bleeding Disorders amid the COVID-19 pandemic: open questions and recommendations (2020) (2)
- Frequency of Antiphospholipid Antibodies in Iranian Patients with Solid Malignan-cies: A Pilot Study (2009) (2)
- Magnetic Resonance Imaging (MRI) Findings of Joints in Young β-Thalassemia Major Patients: Fluid Surrounding the Scaphoid Bone: A Novel Finding, as the Possible Effect of Secondary Hemochromatosis (2007) (2)
- Prevalence of Pyruvate Kinase Deficiency among the Newborns (Shiraz-Iran) (2009) (2)
- Possible Association between Glucose-6- Phosphate Dehydrogenase Deficiency and the Development of Preeclampsia (2010) (2)
- Successful Management of Vinblastin Overdose with Exchange Transfusion: A Case Report (2015) (2)
- Extramedullary Hematopoiesis in a Patient with Transfusion Dependent Beta-Thalassemia Presenting with Cord Compression (2018) (2)
- Long-term safety and efficacy of hydroxyurea in patients with non-transfusion-dependent β-thalassemia: a comprehensive single-center experience (2021) (2)
- COMPARISON OF GROWTH PARAMETERS IN FIVE YEAR-OLD CHILDREN WITH AND WITHOUT HISTORY OF LOW BIRTH WEIGHT (2012) (2)
- Is red cell from an otherwise healthy G6PD-deficient donor efficient for transfusion to fauvism patients? (2009) (2)
- Transcranial Doppler Ultrasonography in Beta-thalassemia Major Patients Without and With Thrombocytosis (2013) (2)
- Correlation between cigarette smoke exposure and prevalence of asthma and allergy symptoms in children, Yazd (2008) (2)
- Prevalence and Mortality Due to Outbreak of Novel Coronavirus Disease (COVID-19) in β-Thalassemias: The Nationwide Iranian Experience (2020) (2)
- Evaluation of Efficacy and Safety of Propranolol for Pediatric Migraine Prophylaxis (2013) (2)
- β-Thalassemia: New Therapeutic Modalities, Genetics, Complications, and Quality of Life (2012) (2)
- Parameters of tissue iron overload and cardiac function in patients with thalassemia major and intermedia (2020) (2)
- Case series of bloody sweating; a scary event for families (2020) (2)
- Prevalence of Helicobacter pylori-associated peptic lesions among patients with sickle cell disease with recurrent abdominal pain. (2008) (2)
- Polymorphisms associated with sickle cell disease in Southern Iran (2012) (2)
- DDAVP Might Reduce the Risk of Preeclampsia in Pregnant Women with VWF Deficiency (2013) (2)
- A national survey of immunosuppression strategies for acquired haemophilia A (2015) (2)
- Low‐dose prophylaxis and its impact on the health of haemophilia patients (2022) (2)
- Safety and efficacy of long‐term emicizumab prophylaxis in hemophilia A with factor VIII inhibitors: A phase 3b, multicenter, single‐arm study (STASEY) (2022) (2)
- Efficacy and safety of fitusiran prophylaxis in people with haemophilia A or haemophilia B with inhibitors (ATLAS-INH): a multicentre, open-label, randomised phase 3 trial (2023) (2)
- Late‐Breaking Abstract (2016) (2)
- Von Willebrand factor – two sides and the edge of a coin (2011) (2)
- The evolving role and future relevance of plasma-derived therapies in the management of bleeding disorders (2016) (2)
- Emergence of occult minority genotype 2b hepatitis C infection in an HIV-1-co-infected patient treated for genotype 5a HCV infection with 48 weeks of pegylated-interferon-alpha 2b and ribavirin. (2007) (2)
- Long-Term Follow-up of Hemophilia a Patients Who Previously Showed Complete or Partial Success in Immune Tolerance Induction Therapy with a Single Plasma-Derived FVIII/VWF Product: Long-Term ITI Study (2015) (2)
- Stable Factor IX Activity Following AAV-Mediated Gene Transfer in Patients with Severe Hemophilia B (2012) (2)
- Challenges of one-year longitudinal follow-up of a prospective, observational cohort study using an anonymised database: recommendations for trainee research collaboratives (2019) (2)
- Apolipoprotein E4 allele and the risk of left ventricular dysfunction in thalassemia major (2007) (1)
- SURVEY INCIDENCE RATE OF BACTERIAL INFECTION IN FEBRILE NEUTROPENIC PATIENT (UNDER 15) ADMITTED IN SHIRAZ MEDICAL HOSPITAL (1379-1380) (2004) (1)
- Prevalence of Discrepancy Between the Results of One-Stage and Chromogenic Factor VIII:C Assays in Iranian Patients with Mild / Moderate Hemophilia A (2016) (1)
- Evolution of glucose-insulin homeostasis in children with β- thalassemia major (β -TM): A twenty-year retrospective ICET- A observational analysis from early childhood to young adulthood (2022) (1)
- Acquired Factor XI Deficiency Associated with Chronic Hepatitis C in Patients with Inherited Bleeding Disorders. (2005) (1)
- Motor Imagery of Typical and High-Functioning Autism Spectrum Disorder Children: Developmental Changes (2020) (1)
- Impact of inherited thrombophilic factors on deep vein thrombosis in individuals in south Iran (2011) (1)
- Serum cancer antigen 15.3 concentrations in patients with betathalassemia minor compared to those with cancer and healthy individuals (2014) (1)
- Ocular findings in patients with transfusion-dependent β-thalassemia in southern Iran (2020) (1)
- The Journal of Clinical Cytology and Cytopathology (2001) (1)
- Hemoaction Game: An educational Step to Improve Hemophilia Children and Nurses Self-Efficacy (2016) (1)
- Comparative evaluation of the safety and efficacy of recombinant FVIII in severe hemophilia A patients (2018) (1)
- DATABASE ON RARE BLEEDING DISORDER (RBDS): PHENOTYPE AND GENOTYPE ANALYSIS ON 400 AFFECTED PATIENTS (2007) (1)
- A Significant Breakthrough in the Incidence of Childhood Cancers and Evaluation of its Risk Factors in Southern Iran (2017) (1)
- Von Willebrand factor propeptide and pathophysiological mechanisms in European and Iranian patients with type 3 von Willebrand disease enrolled in the 3WINTERS‐IPS study (2022) (1)
- Prevalence and Severity of Adolescent Asthma in Yazd, Iran: Based on the 2020 Global Asthma Network (GAN) Survey. (2021) (1)
- P5 Inherited thrombophilia and recurrent pregnancy loss (2009) (1)
- Hemorrhagic symptoms and bleeding risk in obligatory carriers of type 3 von Willebrand disease in southern Iran (2011) (1)
- Inhibitors to factor VII and in congenital factor VII deficiency (2014) (1)
- Effects of three months of treatment with vitamin E and N-acetyl cysteine on the oxidative balance in patients with transfusion-dependent β-thalassemia (2020) (1)
- Survival Rate in Thalassemia Major Patients: Difference between Date of Diagnosis and Date of Birth as an Index Date for Calculating Follow Up (2018) (1)
- Management of haemophilia A with inhibitors: A regional cross‐talk (2022) (1)
- The Effect of Synbiotic Supplementation on Growth Parameters in Mild to Moderate FTT Children Aged 2–5 Years (2019) (1)
- Safety and effectiveness of room temperature stable recombinant factor VIIa in patients with haemophilia A or B and inhibitors: Results of a multinational, prospective, observational study (2017) (1)
- Induction of HBF (2013) (1)
- FOOD CONSUMPTION AND PREVALENCE OF ASTHMA & ALLERGIES SYMPTOMS IN CHILDREN (2011) (1)
- Correlation of Serum Ferritin Levels with Liver and Heart Mri T2 and Liver Iron Concentration in Beta Thalassemia Intermediate Patients: A Contemporary Issue (2016) (1)
- The impact of factor VIII inhibitors on factor consumption in haemophilia: a case-control study in the south of Iran (2011) (1)
- Management of an infant with congenital Factor VII deficiency presenting with obstructed inguinal hernia (2018) (1)
- Thalassemia Intermedia; Folic Acid and Vitamin B12 Supplementation. What We Know and What is Needed? (2017) (1)
- Trace Elements in Children with Acute Lymphoblastic Leukemia. (2021) (1)
- Clinical Evaluation of the New Topical An- esthetic Formulation in β-Thalassemia Major Patients (2009) (1)
- Red Cell Enzymopathies in Patients with Hemolytic Anemia in Southern Iran: Case Series (2016) (1)
- Prevalence of the HFE gene mutation in the liver transplanted and primary hemochromatosis patients in the Southern Iran. (2010) (1)
- Seroprevalence to adeno‐associated virus type 6 in people with hemophilia B from a UK adult cohort (2022) (1)
- The Role of Antithrombin Lowering in Patients with Hemophilia: Hemostatic Control Pre- and Post-Fitusiran Dosing Interruption (2018) (1)
- Is zinc an essential factor in maternal health status and fetal and neonatal growth (2012) (1)
- Bayesian spatial modeling of transfusion-dependent β-thalassemia incidence rate in Fars Province, Southern Iran. (2021) (1)
- Real life experiences of a PK dosing study—Challenges and lessons learned. (2018) (1)
- Association of Exon 14 of the SOX6 Gene Sequence Variations with Response to Hydroxyurea Therapy in Patients Carrying Non Transfusion-Dependent Thalassemia (2020) (1)
- Relationship of the Interaction Between Two Quantitative Trait Loci with γ-Globin Expression in β-Thalassemia Intermedia Patients (2018) (1)
- Identifying the Effects of Education on Burnout in Parents whose Children have Cancer and Presenting Educational-Moral Pattern for Nurses and Nursing Educators in order to Use it in Students' Education (2016) (1)
- Prevalence of JAK2V617F, CALR in Philadelphia Positive and Negative Myeloproliferative Neoplasm (2021) (1)
- MOLECULAR STUDY OF VASCULAR ENDOTHELIAL GROWTH FACTOR GENE IN IRANIAN PATIENTS AFTER MYOCARDIAL INFARCTION (2006) (1)
- The potential correlation between patient-reported symptoms and the use of additional haemostatic medication for joint bleeding in haemophilia patients with inhibitors: a post hoc exploratory analysis of recombinant activated factor VII data from the ADEPT2 trial (2016) (1)
- A Comparison of Efficacy Between Recombinant Activated Factor VII (ARYOSEVEN TM) and NOVOSEVEN® in Patients with Hereditary FVIII Deficiency with Inhibitor (2014) (1)
- Development of a Thalassemia International Prognostic Scoring System (TIPSS). (2022) (1)
- Real-World Early Treatment with Room Temperature–Stable Recombinant Factor VIIa in Hemophilia A/B and Inhibitors: SMART-7™ Post Hoc Analyses (2017) (1)
- Fibrinogen Concentrate vs Cryoprecipitate in Pseudomyxoma Peritonei Surgery: Interim Results from a Prospective, Randomized, Controlled Phase 2 Study (2018) (1)
- Transcranial Doppler Screening in 50 Patients With Sickle Cell Hemoglobinopathies in Iran. (2017) (1)
- Frequency of combined factor V and factor VIII deficiency in southern Iran. (2013) (1)
- Frequency of antiphosholipid antibodies in Iranian patients with solid malignancies: a pilot study. (2009) (1)
- Will gene therapy trump factor treatment in hemophilia? (2013) (1)
- Development of a Severity Score System for Thalassemia Syndromes (2019) (1)
- Frequency of thyroid nodules in patients with β-thalassemias in Southern Iran. (2020) (1)
- Normal Hemoglobin and Hematological Indices in Southwest of Iran (2009) (1)
- Mutational Repertoire in the SIPPET Cohort and Prediction of FVIII Inhibitor Risk (2017) (1)
- Evaluation of Endocrine Complications in Beta-Thalassemia Intermedia Patients: A Cross Sectional Multi-Center Study (2018) (1)
- Differentiation of Fanconi and Aplastic Anemia Using Chromosomal Breakage Test in Southern Iran (2008) (1)
- Inhibitor eradication therapy in non-severe hemophilia A (2012) (1)
- PEDIATRICIAN– BASED MALNUTRITION REDUCTION IN CHILDREN UNDER 5 YEARS OF AGE: AN INTERVENTIONAL PROJECT A HEALTH- TREATMENT CENTER (2010) (1)
- Random Forest Clustering Identifies Three Subgroups of β-Thalassemia with Distinct Clinical Severity (2022) (1)
- Study of Serum Leptin and Ghrelin Levels in Thalassemia Major (2010) (1)
- Down-Regulation of PU.1 Gene in Pediatric Acute Lymphoblastic Leukemia Patients from South of Iran (2019) (1)
- Deferoxamine Protective Effect in Preventing Nephrotoxicity in Children Under Treatment with Doxorubicin: A Randomized Clinical Trial (2019) (1)
- Risk Factors (Adjustment Proteins) and Severity of Coronary Artery Occlusion in Methyl Tetrahydrofolate Reductase Polymorphism (C677T) in the Form of Premature Coronary Artery Disease in Southern Iran (2012) (0)
- LETTER TO EDITOR: IS COLORECTAL CANCER AN UNUSUAL MALIGNANCY AMONG IRANIAN CHILDREN? (2015) (0)
- Frequency of apolipoprotein E alleles in Iranian populations (2006) (0)
- Dosing regimens before and following long-term treatment with recombinant factor VIII Fc fusion protein (rFVIIIFc) in adults and adolescents with severe hemophilia A (2016) (0)
- Clinical Evaluation of the New Topical Anesthetic Formulation in β-Thalassemia Major Patients (2009) (0)
- Table of Contents (2016) (0)
- Expression of the immune checkpoint receptors CTLA-4, LAG-3, and TIM-3 in β-thalassemia major patients: correlation with alloantibody production and regulatory T cells (Tregs) phenotype (2021) (0)
- Pleuropulmonary blastoma is a rare malignancy in young adult and childhood (2015) (0)
- In Vitro Expression Studies And Immunofluorescence Microscopy Analysis Of Two Naturally Occurring Mutations On Factor X (FX) Gene (G94R And D95E) (2005) (0)
- Human-Cl Rhfviii Effectively and Safely Prevents Bleeding Episodes in Previously Treated Adult Patients with Severe Haemophilia A (2012) (0)
- ROLE OF HELICOBACTER PYLORI INFECTION IN SICKLE CELL DISEASE WITH RECURRENT ABDOMINAL PAIN (2005) (0)
- Oncogenic and tumor suppressor genes expression in myeloproliferative neoplasms: The hidden side of a complex pathology (2022) (0)
- A prospective, multicenter, clinical Study to evaluate the Safety, Pharmacokinetics, and Efficacy of Bleed Outcomes, with HemoRel-A® in severe Hemophilia A Patients. (2022) (0)
- The Efficacy and Safety of PPSSB (Human Prothrombin Complex) for Reversal of Oral Anticoagulation. (2005) (0)
- Quality of life: Transfusion dependent thalassemia vs non-transfusion dependent thalassemia (2018) (0)
- This Is a Title : Long Term succsesfull Prophylaxis in 190 Patients with Severe Congenital Factor XIII Deficiency, a Four Years Experience. Here Is the Sub-Title: Succsefull Prophylaxis in Factor XIII Deficiency (2014) (0)
- G6PD deficiency in southern Iran The efficacy of a neonatal screening programme in decreasing the hospitalization rate of patients with (2013) (0)
- Author’s response to reviews Title: Global Longitudinal Strain as an Indicator of Cardiac Iron Overload in Thalassemia Patients Authors: (2019) (0)
- The Use of Factor XI Concentrates (Hemoleven, LFB) in Patients with Congenital Factor XI Deficiency and a Known Bleeding Tendency. (2005) (0)
- Clinical and genetic characteristics of hemoglobin H disease in Iran (2021) (0)
- Three Distinct Groups of Phenotype Severity in Beta-Thalassemia (2020) (0)
- FoxO3a Gene Down-regulation in Pathogenesis of Pediatric Acute Lymphoblastic Leukemia (2019) (0)
- Management of Refractory/RelapsedAcute Leukemia with Heart Limitation byAnthracycline-free ChemotherapyRegimens in Pediatric Patients: NewHypothesis and New Approach (2018) (0)
- Facial palsy as first presentation of acute lymphoblastic leukemia: a case report. (2007) (0)
- Impact of Platelet Glycoprotein Polymorphisms upon Clinical Events in Essential Thrombocythaemia Patients Enrolled in the PT1 Trial. (2007) (0)
- Prediction of Heart and Liver Iron Overload in β-Thalassemia Major Patients Using Machine Learning Methods (2022) (0)
- Evidence for Three Distinct Classes of Phenotype Severity in Beta-Thalassaemia (2019) (0)
- The three I hemophilic study: a comparative study of the morbidity pattern between Asian Indian, Iranian and Italian PWH (2003) (0)
- Thalassemia and Women's Health (2015) (0)
- A Homozygous Mutation on the HBA1 Gene Coding for Hb Charlieu (HBA1: c.320T>C) Together with β-Thalassemia Trait Results in Severe Hemolytic Anemia (2019) (0)
- Von Willebrand Factor antigen and age explain variation in baseline FVIII: C among nonsevere hemophilia A patients with the same F8 genotype (Arg593Cys and Asn618Ser) (2014) (0)
- A PILOT STUDY ON THE RATE OF HEMOGLOBINOPATHIESIN HYPERBILIRUBINEMIC TERM NEONATES AT NEMAZEE HOSPITAL SHIRAZ, IRAN (2006) (0)
- Feiba Global Outcome Study (FEIBA-GO): Long-Term Real World Data on Apcc (FeibaR) in Patients with Inhibitors. First Demographic Data (2016) (0)
- PROTEOMIC ANALYSIS OF PLASMA FROM HAEMOPHILIA A PATIENTS AFTER FACTOR VIII CONCENTRATE INFUSION (2007) (0)
- Clinical haemophilia Long-term safety and efficacy of recombinant factor VIII Fc fusion protein ( rFVIIIFc ) in subjects with haemophilia (2016) (0)
- Clinical presentation of inhibitor development in non-severe hemophilia A: Half of patients have high titer inhibitors and present with bleeding complications (2014) (0)
- Prevalence of Allergic Rhinitis and Eczema in Adolescents Living in Yazd City: Part of Global Asthma Network Survey. (2021) (0)
- Longitudinal Analysis of Long-Term Safety and Efficacy of Recombinant Factor VIII Fc Fusion Protein (rFVIIFc) in Adults/Adolescents with Severe Hemophilia a (2016) (0)
- BONE SCINTIGRAPHY IN ACUTE LYMPHOBLASTIC LEUKEMIA (2015) (0)
- Reversal of Glanzmann's Thrombasthenia & Glycoprotein IIb/Iiia Antagonists by Combined Haemostatic Intervention with Fibrinogen Concentrate and Recombinant Factor VIIa. (2009) (0)
- Protein C concentration in newborn infants with sepsis-like illness (2011) (0)
- Cutaneous finding in anti thymocyte globulin induced serum sickness. (2006) (0)
- OPT002 Swimming exercise ameliorates pain, swelling and bone quality in a blood-induced joint damage animal model (2019) (0)
- aBNORMaL sPLIcING OF MUtaNt BRAF DRIV es R a F IN h IBI tOR R es I sta N ce (2012) (0)
- Prospective Observation on the Use of Von Willebrand Factor (VWF) Concentrates in a Large Cohort of Type 3 Von Willebrand Disease (VWD): Interim (18-months) Analyses on 149 Cases Enrolled into the 3Winters-Ips Project (2018) (0)
- A Comparison Between MRI, Sonography and FISH Methods in Diagnosis, Evaluation and Classification of Arthropathy in Severe Haemophilia a and B (2014) (0)
- Efficacy and safety of factor eight inhibitor bypassing activity prophylaxis evaluation in young patients with hemophilia and high titer inhibitor. (2016) (0)
- Pro‐haemostatic effect of DDAVP is partially derived through non‐classical (CD14dim /CD16 ++) monocytes residing the spleen (2022) (0)
- Haemostasis screening. (2009) (0)
- von Willebrand factor neutralizing and non-neutralizing alloantibodies in 213 subjects with type 3 von Willebrand disease enrolled in 3WINTERS-IPS. (2023) (0)
- Cerebral Artery Velocity in Patients with β-Thalassemia Intermedia Compared to β-Thalassemia Major Using Transcranial Doppler Ultrasonography, (2011) (0)
- Low dose emicizumab prophylaxis in haemophilia a patients: A pilot study from India. (2023) (0)
- Water Only Sequence: An Accurate Method to Estimate Hepatic Siderosis in Patients with Thalassemia Major and Intermedia (2020) (0)
- Fitusiran Reaches People's with Hemophilia and Their Caregivers’ Treatment Expectations: Qualitative Semi-Structured Interviews of Participants of ATLAS-OLE Trial (Interim analysis) (2022) (0)
- Evaluation of Growth Indices and Nutritional Status in Children Hospitalized at the Pediatric Ward of Shahid Sadoughi Hospital in Yazd, Iran in 2020 (2022) (0)
- Successful Delivery of Patients with FXIII Deficiency on Prophylaxis in Iran (2011) (0)
- When and How to Screen for Glucose Dysregulation (GD) in patients with [beta]-Thalassemia Major ([beta]-TM): A retrospective study by The International Network of Clinicians for Endocrinopathies in Thalassemia and Adolescent Medicine (ICET-A) (2022) (0)
- Epidemiologic study of patients with thrombotic events referred to a tertiary hospital in Southern Iran (2021) (0)
- Managing the Mature Person with Hemophilia (2011) (0)
- The use of oral glucose-lowering agents (GLAs) in β-thalassemia patients with diabetes: Preliminary data from a retrospective study of ICET-A Network (2022) (0)
- Long Term Use of Hydroxyurea In Patients with β-Thalassemia In Southern Iran (2010) (0)
- Simultaneous occurrence of obstructive jaundice and proteinlosing enteropathy in Hodgkin’s lymphoma (2015) (0)
- SURVIVAL ANALYSIS OF TRANSFUSION DEPENDENT (2006) (0)
- Adeno-associated virus (AAV)–mediated gene therapy is under investigation as a thera- peutic option for persons with hemophilia A. Efficacy and safety data include 3 years of follow-up after a single administration of AAV5-hFVIII-SQ (2019) (0)
- Correction to: Challenges of one-year longitudinal follow-up of a prospective, observational cohort study using an anonymised database: recommendations for trainee research collaboratives (2020) (0)
- Behcet,s Disease and Brain Tumor- Like Lesion (2008) (0)
- Original Article Frequency of Celiac Disease in Children with Beta Thalassemia major (2014) (0)
- P.145 Selection and persistence of occult minority genotype 2b hepatitis C infection in a patient treated with 48 weeks of pegylated interferon alpha-2b and ribavirin for genotype 5a (2006) (0)
- Epidemiologic study of patients with thrombotic events referred to Dastgheib Thrombosis and Hemostasis Research Center in south of Iran (2015-2017) (2018) (0)
- Expression Analysis of Foxo3a Gene in Pediatric Acute Lymphoblastic Leukemia in Southern Iranian Population (2016) (0)
- Human liver biopsies from people with hemophilia A who received factor VIII gene transfer with valoctocogene roxaparvovec (AAV5-hFVIII-SQ) show unremarkable histopathology and reveal interindividual variability in transgene production (2022) (0)
- A Rare Case of Co-Inheritance of Beta Thalassemia Intermedia and Coagulation FVII Deficiency (2017) (0)
- Rituximab for Treatment of Resistant Inhibitors in Severe Haemophilia a: A Consecutive National Cohort. (2008) (0)
- Does moderate unconjugated hyperbilirubinemia in healthy term neonates play a role on their neurodevelopmental status at the age of 18 months? (2013) (0)
- International Consortium for the Study of Clinical and Molecular Aspects of Bernard-Soulier Syndrome (2011) (0)
- Attitudes and practices of patients with inherited bleeding disorders and the parents of affected children about family planning and prenatal diagnosis in Southern Iran (2013) (0)
- Prevalence of Delta Beta Thalassemia Minor in (2012) (0)
- Role of Stem Cell Transplantation in the Treatment of Burkitt Lymphoma; A Systematic Review (2016) (0)
- Bone mineral density in transfusion-dependent thalassemia patients and its associated factors in Southern Iran (2020) (0)
- Evaluation of prevalence of drug dependence in beta‐thalassemic patients and its risk factors (2008) (0)
- Surrogate measures of insulin secretion and sensitivity (IS) in young children with beta thalassemia major on repeated blood transfusion and iron chelation therapy. (2022) (0)
- A cost-effectiveness analysis of the prophylaxis versus on-demand regimens in severe hemophilia A patients under 12 years old in southern Iran (2021) (0)
- Clustering of Bleeding Symptoms in Patients Previously Diagnosed As Type 3 Von Willebrand Disease: Results from a Large Cohort of Type 3 Von Willebrand Disease (the 3Winters-Ips Project) (2018) (0)
- Impact of Education on Awareness Towards Reproductive Health in Women With Beta-Thalassemia Major (2016) (0)
- Efficacy of Human Fibrinogen Concentrate for on-Demand Treatment of Acute Bleeding and to Prevent Bleeding during and after Surgery in Subjects with Congenital Fibrinogen Deficiency (2016) (0)
- Fibrinogen concentration, gene polymorphisms and venous thrombosis in the black population. (2003) (0)
- Diffuse Hepatic Calcifications in a Transfusion-Dependent Patient with Beta-Thalassemia: A Case Report (2013) (0)
- Dietary Intake of Macro- and Micronutrients in children: Comparison with Reference Values (2021) (0)
- Single Centre Experience of Surgery Management of Patients with Von Willebrand’s Disease Using High Purity Von Willebrand Factor Concentrate with Low Factor VIII Content (2008) (0)
- Pharmacokinetics, Coagulation Factor Consumption, and Product Efficacy in Patients Crossing Over from Full-Length FVIII to B-Domain Deleted R-FVIII and Back to Full-Length FVIII. (2008) (0)
- Investigating Efficacy of Melatonin and Gabapentin in Reducing Anxiety and Pain of Lumbar Puncture in Children (2013) (0)
- Diabetic Ketoacidosis in Children Before and During COVID-19 Pandemic: A Cross-sectional Study (2023) (0)
- Performance of a clinical risk prediction model for inhibitor formation in severe haemophilia A (2021) (0)
- On the Selection of Region of Interest in Measurement of Cardiac Magnetic Resonance Imaging T2* Value in Thalassemia Major Patients (2017) (0)
- Inhibitors increase the burden of disease in nonsevere haemophilia A patients - treatment strategies to obtain hemostasis (2014) (0)
- Quality of life among Iranian patients with beta-thalassemia major using the SF-36 questionnaire Qualidade de vida em pacientes iranianos com beta-talassemia maior usando o questionário SF-36 (2013) (0)
- The Effect of N-Acetyl Cysteine and Vitamin E on Oxidative Status and Hemoglobin Level in Transfusion-Dependent Thalassemia Patients: A Systematic Review and Meta-Analysis (2021) (0)
- Moroctocog Alfa (AF-CC) for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Patients with Hemophilia A in India (2022) (0)
- Nonacog Alfa for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Patients with Moderately Severe or Severe Hemophilia B in India (2022) (0)
- CORRELATION BETWEEN LEFT VENTRICULAR DYSFUNCTION WITH HEMATOLOGICAL PARAMETERS AND IRON CHELATION IN Β-THALASSEMIA MAJOR (2004) (0)
- Epidemiology of prothrombin G20210A polymorphism in the Southern Iran (2015) (0)
- Management strategy to prevent inhibitor development/recurrence in patients with mild/moderate haemophilia A. (2001) (0)
- TET2, DNMT3A, IDH1, and JAK2 Mutation in Myeloproliferative Neoplasms in southern Iran. (2021) (0)
- The Effect of Curcumin on Iron Overload in Patients with Beta-Thalassemia Intermedia. (2022) (0)
- The Influence of F8 Mutation and Thrombophilic Genetic Markers on Bleeding Phenotype of Patients Affected with Severe Hemophilia A in the SIPPET Cohort (2017) (0)
- Haemophilia: A race for cure (2017) (0)
- Thalassemia intermedia registry (2008) (0)
- Study of the Serum Immunoglobulin and Cell-Mediated Immunity in Patients with Congenital Severe Hemophilia. (2021) (0)
- Prediction of Anti-FVIII Inhibitor Persistence By Anti-FVIII IgG Subclasses in Patients with Severe Hemophilia — A in the Sippet Cohort Study (2018) (0)
- P175 Relationship between preeclampsia and glucose‐6‐phosphate dehydrogenase (G6PD) deficiency (2009) (0)
- RNAi for the Treatment of People with Hemophilia: Current Evidence and Patient Selection (2023) (0)
- General principles of good transition care: a short review of the literature (2015) (0)
- Successful Treatment Of Acquired Hemophilia A Using FEIBA Supplemented With Emicizumab (2022) (0)
- Two novel homozygous mutations in the fibrinogen genes identified in two Iranian afibrinogenemic patients (2006) (0)
- Two patients with acquired Factor V deficiency associated with a myeloproliferative disorder. (2002) (0)
- Management of the Sponataneous Bleeding Episodes in Factor VII Deficiency. A Prospective Evaluation of the STER (2011) (0)
- FEIBA Global Outcome Study (FEIBA GO) Data Read-out: Real World Bleeding Frequency in Inhibitors Patients on Prophylaxis with APCC (2017) (0)
- Quality of Life in Children with Rare Bleeding Disorders (2015) (0)
- Thromboprophylaxis Outcome in Childhood SARS-CoV-2 Infection: A Single-Center Experience (2022) (0)
- Profile of Mutations Identified in the 3WINTERS-IPS Project on European & Iranian Patients with Previously Diagnosed Type 3 Von Willebrand Disease. (2018) (0)
- Effectiveness of β‐thalassemia prenatal diagnosis in Southern Iran: a cohort study (2016) (0)
- Women with rare bleeding disorders (2008) (0)
- COVID‐19 and preeclampsia: The unique and the mutually nonexclusive clinical manifestations (2023) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Mehran Karimi?
Mehran Karimi is affiliated with the following schools:
